• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unexpected onset of psoriasis during infliximab treatment: comment on the article by Beuthien et al.

作者信息

Grinblat Beni, Scheinberg Morton

出版信息

Arthritis Rheum. 2005 Apr;52(4):1333-4; author reply 1334. doi: 10.1002/art.20954.

DOI:10.1002/art.20954
PMID:15818679
Abstract
摘要

相似文献

1
Unexpected onset of psoriasis during infliximab treatment: comment on the article by Beuthien et al.
Arthritis Rheum. 2005 Apr;52(4):1333-4; author reply 1334. doi: 10.1002/art.20954.
2
Lack of evidence for erythema multiforme in skin reaction to adalimumab: comment on the article by Beuthien et al.阿达木单抗皮肤反应中多形红斑缺乏证据：对Beuthien等人文章的评论
Arthritis Rheum. 2008 Apr;58(4):1205-6; author reply 1206. doi: 10.1002/art.23408.
3
"Paradoxical" adverse effects caused by anti-tumor necrosis factor-α biological drugs: appearance of psoriasis in a patient treated with infliximab for rheumatoid arthritis.抗肿瘤坏死因子-α生物药物引起的“矛盾性”不良反应：一名类风湿关节炎患者在接受英夫利昔单抗治疗后出现银屑病
Indian J Dermatol Venereol Leprol. 2011 Jul-Aug;77(4):536. doi: 10.4103/0378-6323.82421.
4
Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.一名接受英夫利昔单抗治疗类风湿性关节炎的患者出现了新发银屑病。
Dermatol Online J. 2008 Sep 15;14(9):12.
5
Onset of psoriasis induced by infliximab.英夫利昔单抗诱发的银屑病发病
J Clin Rheumatol. 2008 Apr;14(2):128-9; author reply 130. doi: 10.1097/RHU.0b013e31816b95d4.
6
Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.银屑病和掌跖脓疱病与肿瘤坏死因子-α抑制剂相关：1998 年至 2010 年梅奥诊所的经验。
J Am Acad Dermatol. 2012 Nov;67(5):e179-85. doi: 10.1016/j.jaad.2011.05.038. Epub 2011 Jul 14.
7
Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.类风湿关节炎患者使用肿瘤坏死因子-α抑制剂治疗后出现脓疱型银屑病。
J Drugs Dermatol. 2008 Oct;7(10):975-7.
8
Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?抗肿瘤坏死因子治疗诱发的银屑病：一种类效应？
J Rheumatol. 2007 Feb;34(2):438-9.
9
Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.抗肿瘤坏死因子治疗诱发的银屑病：一种矛盾的不良反应。
Arthritis Rheum. 2005 Aug;52(8):2513-8. doi: 10.1002/art.21233.
10
Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis.阿达木单抗：在银屑病和类风湿关节炎中的疗效与安全性。
Dermatol Ther. 2004;17(5):427-31. doi: 10.1111/j.1396-0296.2004.04045.x.

引用本文的文献

1
Paradoxical Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor-Induced Psoriasis: A Systematic Review of Pathogenesis, Clinical Presentation, and Treatment.矛盾性肿瘤坏死因子-α（TNF-α）抑制剂诱导的银屑病：发病机制、临床表现及治疗的系统评价
Cureus. 2023 Aug 1;15(8):e42791. doi: 10.7759/cureus.42791. eCollection 2023 Aug.
2
Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience.肿瘤坏死因子-α抑制剂诱发的银屑病：临床特征、组织病理学表现及治疗经验的系统评价
J Am Acad Dermatol. 2017 Feb;76(2):334-341. doi: 10.1016/j.jaad.2016.08.012. Epub 2016 Oct 5.
3
Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease.
英夫利昔单抗治疗克罗恩病期间原有银屑病反复出现矛盾性加重
Ann Dermatol. 2009 Feb;21(1):60-2. doi: 10.5021/ad.2009.21.1.60. Epub 2009 Feb 28.
4
The changing face of spondyloarthropathies under TNF α blockade.肿瘤坏死因子α阻断治疗下脊柱关节炎的变化面貌。
Open Rheumatol J. 2008;2:53-7. doi: 10.2174/1874312900802010053. Epub 2008 Nov 14.
5
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.接受抗肿瘤坏死因子α治疗的类风湿关节炎患者新发银屑病的发生率：来自英国风湿病学会生物制剂登记处的结果。
Ann Rheum Dis. 2009 Feb;68(2):209-15. doi: 10.1136/ard.2007.087288. Epub 2008 Apr 2.
6
Psoriasis onset during infliximab treatment: description of two cases.
Rheumatol Int. 2006 Oct;26(12):1158-60. doi: 10.1007/s00296-006-0144-1.